Fondazione Telethon
Celeste Scotti MD, PhD, currently serves as a Member of the Board of Directors at Fondazione AriSLA and as Head of Research and Development at Fondazione Telethon. Prior experience includes serving as Executive Director and Global Program Clinical Head at Novartis, where responsibilities encompassed clinical leadership for programs related to Osteoarthritis and NASH, as well as managing the fast-tracked LNA043 program. Additionally, Celeste has held positions at Libera Università Vita-Salute San Raffaele as a Contract Professor and was a PhD Candidate in Bioengineering at Universitätsspital Basel. Celeste's clinical background includes roles as an Orthopaedic Surgeon and Principal Investigator at ISTITUTO ORTOPEDICO GALEAZZI SPA, and a Resident in Orthopaedic Surgery at the University of Milan. Educational qualifications include an M.D. from Libera Università Vita-Salute San Raffaele, Board Certification in Orthopaedic Surgery, and a Ph.D. from the University of Basel, focusing on Bioengineering and Biomedical Engineering.
This person is not in any offices
Fondazione Telethon
Founded in 1990, Telethon Italy is one of the biggest biomedical charity in Italy, whose mission is to advance biomedical research towards the diagnosis, cure and prevention of muscular dystrophies and other human genetic diseases. Telethon Italy focuses on scientific research and does not offer healthcare, material assistance to patients and families or advocacy. Since 1991, Telethon Italy has invested 394 million Euros in research and funded 2,477 research projects on more than 445 human genetic diseases, which range from basic research to clinical trials.